002772
vs
S
Shanghai Composite
002772
Over the past 12 months, Tianshui Zhongxing Bio-technology Co Ltd has significantly outperformed Shanghai Composite, delivering a return of +119% compared to the Shanghai Composite's +24% growth.
Stocks Performance
002772 vs Shanghai Composite
Performance Gap
002772 vs Shanghai Composite
Performance By Year
002772 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tianshui Zhongxing Bio-technology Co Ltd
Glance View
Tianshui Zhongxing Bio-Technology Co., Ltd. is engaged in the manufacture, research, and development of edible and medical mushrooms. The company is headquartered in Tianshui, Gansu and currently employs 5,588 full-time employees. The company went IPO on 2015-06-26. The firm's edible mushroom products include enoki mushroom, king oyster mushroom and beech mushroom. Through its subsidiaries, the Company also involves in the production and sale of edible mushroom, medicinal mushroom and auxiliary materials, research and development, application and promotion of microbial technology, biological engineering technology and new agricultural technologies, as well as the manufacture, process and distribution of agricultural by-products.
